Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma

[HTML] mdpi.com

[HTML][HTML] A Synopsis of Biomarkers in Glioblastoma: Past and Present

LG Tataranu, S Turliuc, RE Rizea, A Dricu… - Current Issues in …, 2024 - mdpi.com
Accounting for 48% of malignant brain tumors in adults, glioblastoma has been of great
interest in the last decades, especially in the biomolecular and neurosurgical fields, due to …
被引用次数：1 相关文章 所有 5 个版本

Medical and neurologic management of brain tumor patients

JP Ospina, PY Wen - Current Opinion in Neurology, 2024 - journals.lww.com
Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
相关文章 所有 4 个版本
[PDF] oup.com

Differential gene expression underlying epileptogenicity in patients with gliomas

A Mortazavi, AU Khan, E Nieblas-Bedolla… - Neuro-Oncology …, 2024 - academic.oup.com
Background Seizures are a common sequela for patients suffering from gliomas. Molecular
properties are known to influence the initiation of seizures that may influence tumor growth …
相关文章
[PDF] jst.go.jp

脳腫瘍の最新治療

近藤聡英 - 神経治療学, 2024 - jstage.jst.go.jp
抄録 Brain tumors encompass a diverse group of intracranial neoplasms affecting not only
the brain parenchyma but also the meninges and cranial nerves. This inherent …
相关文章 所有 2 个版本